Skip to content

The effect of transcranial direct current stimulation on the StartReact effect: An explorative study.

The effect of transcranial direct current stimulation on the StartReact effect: An explorative study.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23722
Enrollment
10
Registered
2013-04-23
Start date
2013-04-29
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

StartReact effect

Interventions

tDCS (2 mA
15 min) will be applied to one cortical area (M1 on the non-dominant hemisphere). In one session anodal stimulation will be given, in the other session sham stimulation will be given. The order of the

Sponsors

Radboud University Medical Centre Nijmegen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Only healthy, competent, men and women , 18–45 years old, with normal hearing will be recruited.

Exclusion criteria

Exclusion criteria: With regard to transcranial brain stimulation: 1. Serious head trauma or brain surgery; 2. Large or ferromagnetic metal parts in the head (except for a dental wire); 3. Implanted cardiac pacemaker or neurostimulator; 4. Pregnancy. With regard to other experimental techniques: 1. Skin diseases at intended electrode sites (EMG, tDCS). With regard to general experimental requirements: 1. Disorders of hearing; 2. Any neurological or orthopaedic disorder; 3. Cognitive impairments; 4. Any prescribed medication that can alter cortical excitability (e.g. antiepileptics, tricyclic anti-depressives or benzodiazepines) within two weeks prior to participation. Medication negatively affecting balance (e.g. neuroleptics, antidepressants, anticonvulsants, sedatives).

Design outcomes

Primary

MeasureTime frame
The main outcome variable is the reaction time in a simple reaction time task and the onset of postural responses.

Contacts

Public ContactJorik Nonnekes

Radboud University Medical Centre PO Box 9101

j.nonnekes@reval.umcn.nl+31 (0)24 3668425

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)